Sheila Denton
Fortuna: 3 M $ al 31/08/2026
Fortuna: 3 M $ al 31/08/2026
Sheila A. Denton worked at Boehringer Ingelheim USA, Inc. as Secretary, Senior Vice President & General Counsel.
From 2023 to 2025, served at Incyte Corp.
as Secretary, Executive VP & General Counsel.
Education includes undergraduate studies at the University of the Sacred Heart and graduate studies at Western New England University School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INCYTE CORPORATION 0,01 % | 17/11/2025 | 26.569 ( 0,01 % ) | 3 M $ | 31/08/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| INCYTE CORPORATION | Consejero General | 01/12/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
University of the Sacred Heart
University of the Sacred Heart Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western New England University School of Law
Western New England University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.